WWEST PHARMACEUTICAL SERVICES INC logo
WST//CIK 0000105770

WEST PHARMACEUTICAL SERVICES INC

Exchange

NYSE

Entity type

operating

Fiscal year end

Dec 31

Headquarters

PA

Research Summary

AI-assisted · Grounded in filings

Updated Nov 24, 2025

WEST PHARMACEUTICAL SERVICES INC

West Pharmaceutical Services Inc. builds drug containment and delivery platforms that pair polymer and elastomer components with advanced design, and it sits squarely in SIC 3845′s medical instruments space where precision and regulatory adherence define competitive advantage; its products span stoppers, seals, custom components and integrated systems that help biopharma and device makers bring injectable therapies to market while meeting sterility, compatibility and regulatory documentation demands, and its service model includes engineering support, validation testing and logistics for global clinical and commercial programs. Target customers are large and mid-size pharmaceutical, biotechnology and diagnostic companies that rely on West to safeguard sensitive biologics and vaccines throughout filling, storage and administration, and the company must continuously navigate material risks such as supply-chain disruptions, raw-material concentration, quality nonconformances, and evolving FDA, EMA and other jurisdictional rules governing combination products and sterile manufacturing; the latest filing data is pending and will inform how those dynamics are playing out. For the most current disclosures, check live SEC filings on Earnings Feed.

Market Data

Dec 4, 9:30 AM ET
$281.77−$5.17 (−1.80%)

WST · Last trade

Prev Close

$286.94

Range (29d)

$257.77 – $284.31

$240.00$260.00$280.00$300.00Nov 5Nov 14Nov 24Dec 4